WaratekVRT Sign in
Reset
More filters (2)
Columns
Protection: None✕Product life sciences central coding✕
Overview 1 match · 0 protected · 0 exploited · 0 CISA KEV · 0 public PoC · 0 EPSS ≥ 0.5
1match 0protected0.0% 0exploited0.0% 0CISA KEV0.0% 0public PoC0.0% 0EPSS ≥ 0.50.0%
Protected by Waratek 0 0.0% Rule in development 0 0.0% Mitigation candidate 0 0.0% No exploit published 1 100.0%
Critical 0 0.0% High 0 0.0% Medium 1 100.0% Low 0 0.0% None 0 0.0% Unknown 0 0.0%
blocked by ARMR today 0 0.0% partly blocked 0 0.0% not blocked 1 100.0% not established 0 0.0% unrecorded 0 0.0%
Exploited 0 0.0% Working exploit published 0 0.0% Proof of concept only 0 0.0% Forecast only 0 0.0% No public exploit 1 100.0%
split by peak 1 / month
No exploit published: 1 Medium: 1 not blocked: 1 No public exploit: 1
Jan 261 No exploit published1 Medium1 not blocked1 No public exploit1
Jan 26
1 match Sign in to download these CVEs as CSV or JSON, or to follow them in a feed.
CVE Severity Published▾ Status Exploitation Description
CVE-2026-21980 Medium 2026-01-20 No exploit published No public exploit Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).